USPTO serial 75208771
ABICAP
Reviewed by CopyMark Law Group
Reg. 2229905Status 710
- Filing date
- Status date
- Registration date
- Mar 9, 1999
- Examiner
- KUHLKE, KAREN
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with ABICAP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
ABION Beteiligungs- und Verwaltungsgesellschaft mbH
D-52428 Julich, DE
Other trademarks owned by ABION Beteiligungs- und Verwaltungsgesellschaft mbH
ABION Beteiligungs- und Verwaltungsgesellschaft mbH
D-52428 Julich, DE
Other trademarks owned by ABION Beteiligungs- und Verwaltungsgesellschaft mbH
ABION Beteiligungs- und Verwaltungsgesellschaft mbH
D-52428 Julich, DE
Other trademarks owned by ABION Beteiligungs- und Verwaltungsgesellschaft mbH
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
STEPHEN A BENT
STEPHEN A BENT FOLEY & LARDNERP O BOX 25696WASHINGTON, DC 20007-8696UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | chemicals and biochemicals used in industry and science, namely, test kits consisting primarily of reagents for the detection of various disease stages and diesease stage metabolites, for research and analytical use in environmental engineering, medicine and biotechnology; material for performing bioassays, namely, particulate and fibrous materials, namely, inorganic and organic polymer-based matrices in bulk, gel or molded form for use in test kits comprising primarily reagents for the detection of various disease stages and disease stage metabolites sold separately and as the primary component of test kits for research use and analytical investigation; research test kits consisting primarily of reagents for use in detecting different illness stages or metabolites indicating a particular illness stage; immunoanalytic test kits consisting primarily of immunoreagents, namely, antibodies and antigens for assaying and detecting substances; all the above also for monitoring of biochemical production and environmental analysis and food analysis | SECTION 8 - CANCELLED | — |
| 005 | medical diagnostic test kits consisting primarily of reagents for use in detecting different illness stages or metabolites indicating a particular illness stage; medical diagnostic immunoanalytic test kits consisting primarily of immunoreagents, namely, antibodies and antigens for detecting and assaying biochemical or organic substances | SECTION 8 - CANCELLED | — |
| 009 | scientific apparatus and instruments, namely, chromatographic columns sold empty or filled with materials for bioassays, medical assays or immunoassays for scientific research use; laboratory equipment, namely, syringes; hollow bodies having several separated chambers for storing and releasing assay reagents; electric apparatus, namely, robots for automatically performing assay steps, such as gripping of columns, pipetting and dosage of test reagents and samples; detectors, namely, photometers, detectors for measuring weight, magnetism, light scattering, density, light intensity, light wavelength, luminescence, luminous flux, illumination, brightness, electrical signals, electromagnetic energy, number of particles, size of particles, density, or gravimetric properties for use in scientific research and analytical investigations; computer software for use in performing and evaluating diagnostic tests in the field of detection of various disease stages and disease stage metabolites | SECTION 8 - CANCELLED | — |
| 010 | medical diagnostic test kits consisting primarily of columns, reagents or immunoreagents in aqueous solutions or in lyophilized form for use in detecting different illness stages or metabolites indicating a particular illness stage; medical diagnostic apparatus for detecting different illness stages or metabolites indicating a particular illness stage; medical diagnostic apparatus for in vitro examinations for the treatment or diagnosis of a specific disease or condition; cannulas; medical syringes, hollow bodies having several separated chambers for storing and releasing assay reagents for medical diagnostic use, electric apparatus, namely, robots for performing automatically assay steps, such as gripping of columns, pipetting and dosage of test reagents and samples for medical diagnostic use; detectors, namely, photometers, detectors for measuring weight, magnetism, light scattering, density, light intensity, light wavelength, luminescence, luminous flux, illumination, brightness, electrical signals, electromagnetic energy, number of particles, size of particles, density, or gravimetric properties for medical diagnostic use | SECTION 8 - CANCELLED | — |
| 016 | printed matter, namely, newsletters, textbooks, brochures, magazines, manuals in the field of promotion, information, training, research, user instructions, each in the field of assay technology | SECTION 8 - CANCELLED | — |
| 041 | publication of text books for scientific instruction | SECTION 8 - CANCELLED | — |
| 042 | laboratory research in the field of assay technology | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ABION Beteiligungs- und Verwaltungsgesellschaft mbH
- Other trademarks owned by ABION Beteiligungs- und Verwaltungsgesellschaft mbH
- Other trademarks owned by ABION Beteiligungs- und Verwaltungsgesellschaft mbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 016
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named ABICAP
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 17, 2005 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Mar 9, 1999 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 15, 1998 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 13, 1998 | NPUB | NOTICE OF PUBLICATION | — |
| Oct 3, 1998 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 24, 1998 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 24, 1998 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 24, 1997 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 24, 1997 | 1.BD | Sec. 1(B) CLAIM DELETED | — |
| Jun 26, 1997 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 25, 1997 | DOCK | ASSIGNED TO EXAMINER | — |